Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xanthone derivatives as potential anti-cancer drugs

C N Lin1, S J Liou, T H Lee

  • 1School of Pharmacy, Kaohsiung Medical College, Taiwan, Republic of China.

The Journal of Pharmacy and Pharmacology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dramatic band gap reduction incurred by dopant coordination rearrangement in Co-doped nanocrystals of CeO<sub>2</sub>.

Scientific reports·2017
Same author

Targeting microglial activation in stroke therapy: pharmacological tools and gender effects.

Current medicinal chemistry·2013
Same author

Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation.

Journal of viral hepatitis·2012
Same author

Generation of a novel factor IX with augmented clotting activities in vitro and in vivo.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Superior mesenteric artery syndrome in a tetraplegic patient, 11 years after a spinal cord injury: a case report.

Spinal cord·2010
Same author

Multiple myeloma uncovered by investigating a negative serum iron level.

Journal of clinical pathology·2007

New xanthone derivatives show potent anti-tumour activity by inhibiting cancer cell growth and DNA, RNA, and protein synthesis. Specifically, compound 12a targets the Ha-ras oncogene, offering a promising new avenue for cancer therapy.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Oncology

Background:

  • Xanthone derivatives are recognized for their potential as anti-cancer agents.
  • Previous research suggests xanthones can inhibit tumor growth.

Purpose of the Study:

  • To synthesize and evaluate novel xanthone derivatives for their in-vitro anti-tumour activity.
  • To investigate the structure-activity relationships of these compounds.
  • To assess the impact of specific xanthone derivatives on cancer cell proliferation and oncogene expression.

Main Methods:

  • Synthesis of oxygenated xanthones and [3-(dialkylamino)-2-hydroxypropoxy]xanthones.
  • In-vitro cytotoxicity assays against human cancer cell lines (PLC/PRF/5, KB, 212).
  • Structure-activity relationship analysis, including epoxidation and ring-opening modifications.

Related Experiment Videos

  • Evaluation of DNA, RNA, and protein synthesis inhibition in tumour cells.
  • Assessment of activity against Ha-ras oncogene-transformed NIH 3T3 cells (212 cell line).

    • Main Results:

    • Epoxidation of hydroxyxanthones enhanced cytotoxicity against tumour cells.
    • Ring-opening of the epoxide group with dialkylamine did not improve anti-tumour activity.
    • Compounds 10a, 11a, and 12a demonstrated potent inhibition of DNA, RNA, and protein synthesis.
    • Compound 12a (3,5-di(2,3-epoxypropoxy)xanthone) showed significant activity against 212 cells, including specific inhibition of the Ha-ras oncogene.

    Conclusions:

    • Compounds 10a and 12a are potent anti-tumour agents.
    • These compounds effectively suppress tumour cell DNA, RNA, and protein synthesis.
    • Compound 12a exhibits specific inhibitory activity against the Ha-ras oncogene, highlighting its potential as a targeted cancer therapeutic.